Bingham Osborn & Scarborough’s Adamas Pharmaceuticals ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $142K | Sell |
|
|||||
|
2020
Q2 | $441K | Hold |
|
|||||
|
2020
Q1 | $498K | Sell |
|
|||||
|
2019
Q4 | $985K | Buy |
|
|||||
|
2019
Q3 | $727K | Hold |
|
|||||
|
2019
Q2 | $881K | Sell |
|
|||||
|
2019
Q1 | $1.04M | Buy |
|
|||||
|
2018
Q4 | $1.15M | Buy |
|
|||||
|
2018
Q3 | $2.61M | Hold |
|
|||||
|
2018
Q2 | $3.37M | Sell |
|
|||||
|
2018
Q1 | $3.13M | Buy |
|
|||||
|
2017
Q4 | $4.15M | Buy |
|
|||||
|
2017
Q3 | $2.58M | Hold |
|
|||||
|
2017
Q2 | $2.13M | Hold |
|
|||||
|
2017
Q1 | $2.13M | Buy |
|
|||||
|
2016
Q4 | $1.99M | Sell |
|
|||||
|
2016
Q3 | $3.85M | Hold |
|
|||||
|
2016
Q2 | $3.56M | Buy |
|
|||||
|
2016
Q1 | $434K | Hold |
|
|||||
|
2015
Q4 | $850K | Hold |
|
|||||
|
2015
Q3 | $502K | Hold |
|
|||||
|
2015
Q2 | $787K | Buy |
|